Nutraceuticals in India: A step towards empowering Pharma Industry

There's a pressing demand for specialized nutraceutical products targeting various age groups, particularly infants and children after the breastfeeding phase.

Picture: Pixabay

Last Updated on September 15, 2023 by The Health Master


In a significant stride towards self-reliance, the Indian pharmaceutical industry is exploring the production of nutraceuticals, leveraging its expertise in cutting-edge technologies.

These capabilities encompass a range of innovations, from modified drug delivery systems to sterile parenteral nutrition for intravenous administration, blended granules, and powders.

This move aligns perfectly with the vision of Atmanirbhar Bharat of a self-reliant India.

Enhancing Palatability and Stability

DBA Narayana, a prominent figure in the industry, emphasizes that the Indian pharma sector excels in enhancing the palatability of nutraceutical products, surpassing the offerings currently imported.

Additionally, the industry possesses the know-how to develop stable formulations tailored for the Indian and Asian populations.

Critical to this endeavor is the measurement science proficiency, necessary to ensure the precise presence of desired nutrients while eliminating unwanted elements.

Furthermore, there’s potential for the domestic production of specific nutrients on a commercial scale.

Shedding Light on Lactose Intolerance and IEM

For decades, lactose intolerance, a condition stemming from a genetic disorder hindering lactose metabolism, has lingered in the background.

Yet, with the advancement of science and technology, it’s emerged as a significant factor contributing to the mortality of newborns and young children.

Meeting the Demand for IEM Products

The market for products tailored for infants with Inborn Errors of Metabolism (IEM) is on the rise, not only in India but across Asia.

Addressing this surge in demand requires a strategic approach.

There’s an urgent need for innovations in producing specialized dietary products designed for individual IEM disorders in infants.

Simultaneously, efforts should focus on establishing indigenous production and affordable accessibility of these products, along with the development of screening test kits, catering specifically to the Indian and Asian populace.

Given the prowess of the Indian pharma industry, navigating the regulatory landscape for these products appears feasible.

Understanding Inborn Errors of Metabolism

IEMs, often arising from defects in specific protein enzymes responsible for food metabolism, encompass a range of disorders.

Examples include:

  • Organic acidurias,
  • Fatty acid oxidation defects,
  • Urea cycle disorders,
  • Mitochondrial diseases,
  • Galactosemia,
  • Maple syrup urine disease,
  • Fructose intolerance, and
  • Phenylketonuria.

Empowering Healthcare Professionals

Previously, pediatricians, pediatric nutritionists, and gynecologists grappled with the lack of knowledge regarding these conditions in newborns.

However, over the past one to two decades, scientific progress has revolutionized early detection through newborn screening tests.

This breakthrough enables early intervention, providing infants with IEM the opportunity to lead healthy lives by carefully managing their diets.

Tailoring Nutraceuticals for Different Age Groups

There’s a pressing demand for specialized nutraceutical products targeting various age groups, particularly infants and children after the breastfeeding phase.

These products, typically in powder form, are meticulously blended with proteins, fats, and carbohydrates, designed to cater to specific IEMs.

For instance, a product for maple syrup urine disease must be devoid of isoleucine, leucine, and valine, while a formulation for glutaric acidemia Type 1 should exclude lysine and tryptophan.

The innovation potential for the Indian pharma industry in this arena is substantial.

A Vision for the Future: Self-Reliance in Nutraceuticals

As India charts its course towards self-reliance, the foray into nutraceutical production is a pivotal step.

With its technological prowess and scientific acumen, the Indian pharma industry stands poised to revolutionize the landscape, providing tailored solutions for infants and children with IEMs.

This move not only bolsters the domestic market but also positions India as a potential hub for nutraceutical innovation and production on a global scale.

Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.

Nutraceutical Industry: Opportunities and Measures for India

Nutraceutical industry trends will rule the year

IPA calls Nutraceutical, Pharma industries to join hands to provide holistic care

Regulatory framework for Nutraceutical industry

Nutraceuticals Regulations 2022 to encourage Pharma Industry

Nutraceuticals: India can become a Global Leader

Nutraceuticals: A strong Regulation is needed

Bring Nutraceuticals for prevention of diseases under DCGI’s regulation: Experts to Govt

Nutraceuticals for mental well-being

Nutraceuticals: From Alternative to Mainstream

Nutraceuticals in India: A game changing opportunity

Indian Nutraceutical industry now a days

Nutraceutical Industry: A trending Market

PLI scheme: Boost for the growth of the Nutraceutical sector

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
YouTube Icon